Edinburgh, United Kingdom, 7 June 2023: The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of cell and gene therapies, has today officially opened its facility in the Edinburgh BioQuarter, its first site in Scotland. The new laboratories and offices were opened by Michael Matheson, Scottish Government Cabinet Secretary for NHS Recovery, Health and Social Care.
By opening these new laboratories, the CGT Catapult aims to provide expertise, resources and technology to help cell therapy developers improve their manufacturing processes and navigate the complex regulatory requirements involved in bringing their therapies to market.
Edinburgh has become a world-leading hub for stem cell research, and the new space, located in the University of Edinburgh’s Institute of Regeneration and Repair, will build on and support the region’s academic strength.
The 350m2 high-specification laboratory space is equipped with state-of-the-art technologies to help cell therapy developers establish robust manufacturing processes for their therapies. Cell therapies are treatments which repair or replace cells and tissues to either restore normal function or enhance their ability to fight diseases, such as cancer…Read more
